期刊文献+

犬冠状病毒S糖蛋白基因重组犬2型腺病毒的构建及其免疫原性研究 被引量:3

Construction of recombinant Canine adenovirus type 2 expressing Canine coronavirus spike glycoprotein and its immunogenicity
下载PDF
导出
摘要 首次构建了能表达犬冠状病毒纤突糖蛋白(CCVS1)的重组犬2型腺病毒(CAV-2)。用RT-PCR方法从CCVDXMV株细胞培养物中扩增出编码S糖蛋白A、B、C和D4个抗原位点的基因片段S1,将其克隆到pVAX1中,然后将含有CCVS1基因的完整表达盒(CMV-S1-PolyA)进一步定向克隆到含有CAV-2E3区的穿梭质粒pVAXE3中,构建出pVAX△E3S1。通过SalⅠ+NruⅠ双酶切pVAX△E3S1回收含有目的基因的表达盒,将其克隆入含有CAV-2全基因组的骨架质粒pPoly2-CAV-2中,获得重组质粒pCAV-2-CCV-S1。ClaⅠ+AscⅠ酶切pCAV-2-CCV-S1释放重组基因组,转染MDCK细胞,获得了重组病毒CAV-2-S1。该重组病毒在MDCK细胞上能产生典型的腺病毒细胞病变。通过mRNA水平和Westernblot检测,证实重组病毒能表达CCVS1蛋白。动物免疫试验表明,该重组病毒可以有效地诱导免疫犬产生抗CCV和CAV-2抗体。 In order to construct a recombinant Canine adenovirus type 2 (CAV-2) expressing the spike glycoprotein of Canine coronavirus (CCV), the S1 gene fragment of CCV strain DXMV, encoding major antigenic region A, B, C and D of S protein, was amplified by RT-PCR and cloned into pVAX1 vector. The complete S1 expression cassette was subcloned into the shuttle vector pVAXE3, then further cloned into the backbone vector pPoly2-CAV2 containing complete genome of CAV-2.To gain the recombinant Canine adenovirus, the recombinant plasmid pCAV-2-CCV-S1 was linearized by ClaⅠ/AscⅠ to release recombinant genome, and then transfected into MDCK cell. The recombinant virus CAV-2-S1 was gained through 4 passages in MDCK, which showed classical CPE of CAV-2.The expressed S1 protein of CCV, which was identified by RT-PCR and Western blot, can be specifically recognized by polyclonal antibody against CCV. The immunization in dogs indicated that the recombinant CAV-2 could effectively induce the specific antibodies against CCV and CAV.
出处 《微生物学报》 CAS CSCD 北大核心 2005年第4期588-592,共5页 Acta Microbiologica Sinica
基金 国家自然科学基金资助项目(30000123) 全军"十五"医药卫生重点项目(Z2001095)~~
关键词 犬冠状病毒 纤突糖蛋白 重组犬2型腺病毒 Canine coronavirus, Spike Glycoprotein, Recombinant Canine adenovirus type 2
  • 相关文献

参考文献18

  • 1Tennant B J, Gaskell R C, Jones C J, et al. Studies on the epizootiology of canine coronavirus. Veterinary Record, 1993, 132(2) :7 - 11.
  • 2Carmichael L E. Canine viral vaccines at a turning point-a personal perspective. Adv Vet Med, 1999,41: 289 - 307.
  • 3Horsburgh B C, Brierley I, David K B T, et al. Analysis of a9.6kb sequence from the 3′end of canine coronavirus genomic RNA.J Gen Virol, 1992,73:2849 - 2862.
  • 4Wesseling J G, Vennema H, Godeke G J, et al. Nucleotide sequence and expression of the spike (S) gene of canine coronavirus and comparison with the S proteins of feline and porcine coronavirus. J Gen Virol, 1994,75:1789 - 1794.
  • 5乔军,夏咸柱,胡桂学,谢之景,闫芳,杨松涛,黄耕.犬冠状病毒大熊猫株纤突蛋白全基因的克隆与序列分析(英文)[J].中国病毒学,2004,19(5):481-486. 被引量:2
  • 6Rosenthal K L, Copeland K F T, Gallichan W S. Recombinant adenovirus as vectors for mucosal immunity. Mucosal vaccines. San Diego: Academic Press, 1996,147 - 158.
  • 7Papp Z, Middeltown D M, Mittal S K, et al. Mucosal immunization with recombinant adenoviruses: induction of immunity and protection of cotton rats against respiratory bovine herpesvirus type Ⅰ infection.J Gen Virol, 1997,78:2933 - 2943.
  • 8Papp Z, Babiuk L A, Baca-Estrada M E. The effect of pre-existing adenovirus-specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1. Vaccine, 1999,17:933 - 943.
  • 9Baer G M, Brooks R C, Foggin C M. Oral vaccination of dogs fed canine adenovirus in baits. Am J Vet Res, 1989,50:836 - 837.
  • 10Summer J W, Shaddock J H, WuGJ, etal. Oral vaccination of an attenuated strain of canine adenovirus (type 2) to raccoons, foxes,skunk and mongoose. Am J Vet Res, 1988,49:169- 171.

二级参考文献28

  • 1萨姆布鲁克J 金冬雁(译).分子克隆实验指南[M].北京:科学出版社,1992.55-56.
  • 2Delmas B, Rasschaert D, Gtodet M, et al. Four major antigenic site of the coronavirus transmissible gastroanteritis virus are located on the amino-terminal half of spike glycoprotein S [J]. J Gen Virol. 1990, 71:1313-1323.
  • 3Simpkins R A, Weilnau P A, Bias J, et al. Antigenic variation among transmissible gastroenteritis virus (TGEV) and porcine respiratory coronavirus strains detected with monoclonal antibodies to the S protein of TGEV[J]. Am. J. Vet. Res. 1992, 53: 1253-125
  • 4Wesley R D. The S gene of canine coronavirus, strain UCD-1, is more closely related to the S gene of transmissible gastroenteritis virus than to that of feline infectious peritonitis virus[J]. Virus Res.1999, 61(2):145-152.
  • 5Ying Z, Liu J H. Animal virology [M] (second edition). Beijing:Science press. 1997, 671-703.
  • 6Correa I, Jimenez G, Sune C, et al. Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus[J]. Virus Res. 1988, 10: 77-94.
  • 7Falima G, Willewp A, Correa C, et al. Residues involved in the antigenic sites of transmissible gastroenteritis virus S glycoprotein [J].J Virol. 1991,183: 225-238.
  • 8Christine K, Graham D, Yolken R, et al. Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity ofTGEV[J]. J Virol. 1997, 71 (4): 3285-3287.
  • 9Pratelli A, Martella V, Decaro N, et al. Genetic diversity of a canine coronavirus detected in pups with diarrhea in Italy[J]. J Virol Methods. 2003, 110(1): 9-17.
  • 10Pratelli A, Decaro N, Tinelli A, et al. Two genotypes of canine coronavirus simultaneously detected in the fecal samples of dogs with diarrhea[J]. J Clin Microbiol. 2004, 42:1797-1799.

共引文献53

同被引文献51

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部